Product Description:
Niraparix is a once-daily, oral medicine used for the maintenance treatment of women with recurrent ovarian, fallopian tube, or primary peritoneal cancer when their cancer comes back. Niraparix is the first and only once-daily PARP inhibitor used after the cancer has responded (complete or partial response) to treatment with platinum-based chemotherapy
Product Features:
| Product Name | Niraparix |
| Generic Name | Niraparib |
| Formulation | Capsule |
| Available Strength | 100 mg |
| Registrations | Available |
